Development and Validation of HPTLC SIAM for Furosemide and Spironolactone

Suvarna S. Vanjari* and Tushar A. Deshmukh

TVES’s, Hon. Loksevak Madukarrao Chaudhari College of Pharmacy, Faizpur, Jalgaon- 425503, Maharashtra, India

Corresponding Author E-mail: vanjarisuvarna19@gmail.com

DOI : http://dx.doi.org/10.13005/bbra/3125

ABSTRACT: "Diuretics," like spirolactone and furosemide, help the kidneys eliminate excess water. It also reduces fluid-induced hypertension and maintains blood potassium levels. Both Furosemide (FRU) and Spironolactone (SPL) can be measured at the same time with the help of HPTLC chromatographic method that have been shown to be very selective and accurate. There are a number of causes of edema, and FRU can help with all of them, including hepatic cirrhosis, chronic congestive heart failure, and excessive blood pressure. Heart failure and ascites caused by hepatic diseases are commonly treated with spironolactone due to its properties as an aldosterone antagonist and potassium-sparing diuretic. HPTLC methods were developed in this research to determine FRU and SPL simultaneously without using the solvents generally needed in chromatographic procedures. The proposed HPTLC approach stood out as an analytical method for quality control laboratories due to its speed, low cost, and ability to concurrently determine the target chemicals with a small number of solvents. The selectivity, accuracy, and reproducibility of the procedures for the simultaneous determination of the pure and mixed drug forms studied were further confirmed by statistical analysis.

KEYWORDS: Furosemide; HPTLC; HPLC; Spironolactone; Validation

[ HTML Full Text]